Clinical trial
Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary…
NCT00120380 · Hannover Medical School, Other · Terminated
Key facts
| NCT number | NCT00120380 |
|---|---|
| Title | Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH) |
| Official title | Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension |
| Lead sponsor | Hannover Medical School, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Aerosolized iloprost, Placebo |
| Enrollment | 40 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jul 18, 2005 |
| Last update posted | Aug 21, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: